Cynthia M. Butitta
2008
In 2008, Cynthia M. Butitta earned a total compensation of $848.6K as Chief Operating Officer and Chief Financial Officer at MabVax Therapeutics Holdings, a 64% increase compared to previous year.
Compensation breakdown
| Option Awards | $469,616 |
|---|---|
| Salary | $379,000 |
| Total | $848,616 |
Butitta received $469.6K in option awards, accounting for 55% of the total pay in 2008.
Butitta also received $379K in salary.
Rankings
In 2008, Cynthia M. Butitta's compensation ranked 4,897th out of 9,135 executives tracked by ExecPay. In other words, Butitta earned more than 46.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,897 out of 9,135 | 46th |
Division Manufacturing | 1,766 out of 3,436 | 49th |
Major group Chemicals And Allied Products | 349 out of 815 | 57th |
Industry group Drugs | 209 out of 597 | 65th |
Industry Pharmaceutical Preparations | 153 out of 408 | 63rd |
Source: SEC filing on April 7, 2010.
Butitta's colleagues
We found four more compensation records of executives who worked with Cynthia M. Butitta at MabVax Therapeutics Holdings in 2008.
2008
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2008
Stefan Ryser
MabVax Therapeutics Holdings
Former Senior Vice President, Corporate Strategy
2008
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2008
Marc Steuer
MabVax Therapeutics Holdings